Drug trial, dubbed ‘Master Protocol,’ uses tumor genomics to customize treatments

px DNA methylation
Credit: Christoph Bock, via Wikimedia Commons


Drug trials based on a tumor’s genetic profile is the future of cancer drug research, allowing researchers to accept a wide variety of patients into clinical trials.

Cancer drugs are developed to target molecular abnormalities in tumors, but each abnormality is extremely rare, so patients with the same kind of cancer generally do not have identical tumors. When screening patients for drug trials, researchers must comb through hundreds of potential patients before they can find even one whose cancer matches the genetic profile a specific drug was created to target.

Vali Papadimitrakopoulou, an oncologist at the MD Anderson Cancer Center in Houston is the head of a new trial, dubbed “The Master Protocol,” that will test drugs on squamous cell lung cancer based on the unique DNA of each participant’s tumors. Papadimitrakopoulou and his team compiled “the most common genomic profiles” of squamous cell lung cancer and then identified novel drugs that “could address each form of the disease.”

Papadimitrakopoulou and his colleagues will begin the innovative drug trial in 2014. They are anticipating the new trial method will be expanded to include other types of cancer, and potentially other types of diseases as well.

Read the full, original story here: Genomics Could Blow Up the Clinical Trial

Additional Resources:



Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend